Healthy volunteers needed to compare two drug versions
NCT ID NCT07633691
First seen Jun 11, 2026 · Last updated Jun 18, 2026 · Updated 2 times
Summary
This early-stage study tests the safety and how the body processes two versions of an experimental drug (DA-5223 and DA-5223-R) in 12 healthy adults aged 19 to 55. Participants receive a single dose of each version in random order, and researchers measure drug levels in the blood. The goal is to gather information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bumin hospital
RECRUITINGGangseo-gu, Seoul, 07590, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.